期刊文献+

抑癌基因PTEN在泌尿系肿瘤发生发展中的作用 被引量:1

The Study of Tumor Suppressor Gene PTEN in the Carcinoma of Urinary System
下载PDF
导出
摘要 第10号染色体同源丢失性磷酸酶-张力蛋白基因(PTEN)具有磷酸酶活性及抑癌活性。PTEN的突变缺失是包括泌尿系肿瘤等各种肿瘤发生发展的基础。研究显示,由于PTEN的突变、缺失而丧失抑癌作用而致肾癌、膀胱癌、前列腺癌的发生,揭示了PTEN具有抑制泌尿系肿瘤发生的作用。但是,PTEN抑癌作用及丢失、突变的一些具体过程还不是很清楚,有待进一步的明确。 PTEN( phosphatase and tensin homolog deleted on chromosome ten)is phosphatase specificity and can inhibit oncogenesis. The mutation and loss of PTEN is the oncogenesis basis of all kinds of tumor, including urinary system tumor. Studies show that mutation and loss of PTEN, which can lead to the dysfunction of tumor suppress, induced oncogcnesis of renal cell carcinoma, bladder carcinoma and prostatic carcinoma, revealling that PTEN can inhibit tumorigenesis of urnary system. But the detail of the mutation and loss of PTEN and how PTEN inhibit tumorigensis are still unclear,further study is warranted.
作者 王宇 葛波
出处 《医学综述》 2009年第24期3699-3701,共3页 Medical Recapitulate
关键词 第10号染色体同源丢失性磷酸酶-张力蛋白基因 肾癌 膀胱癌 前列腺癌 Phosphatase and tensin homology deleted on chromosome ten Renal cell carcinoma Bladder carcinoma Prostatic carcinoma.Key words:Phosphatase and tensin homology deleted on chromosome ten Prostatic carcinoma
  • 相关文献

参考文献9

二级参考文献75

  • 1王亚明,田增民.PTEN肿瘤抑制基因和细胞间信号传导研究进展[J].海军总医院学报,2004,17(3):167-171. 被引量:5
  • 2张振新,邱晓霞,达鹏,周维镕.喉鳞状细胞癌中PTEN蛋白表达与微血管密度的相关性[J].江苏医药,2006,32(7):607-609. 被引量:3
  • 3吴阶平.吴阶平泌尿外科学[M].济南:山东科学技术出版社,2004.589-591.
  • 4CANTLEY L C,NEEL B G.New insights into tumor suppression:PTEN suppression tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway[J].Proc Natl Acad Sci USA,1999,96(8):4240-4245.
  • 5WANG DS,RIEGER-CHROST K,LATINI J M,et al.Molecular analysis of PTEN and MXI1 in primary bladder carcinoma[J].Int J Cancer,2000,88(4):620-625.
  • 6CAIRNS P,EVRON E,OKAMI K,et al.Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers[J].Oncogene,1998,16 (24):3215-3218.
  • 7AVEYARDJ S,SKILLETER A,HABUCHI T,et al.Somatic mutation of PTEN in bladder carcinoma[J].Br J Cancer,1999,80(5/6):904-908.
  • 8LIU J,BABAIAN D C,LIEBERT M,et al.Inactivation of MMAC1 in bladder transitional-cell carcinoma cell lines and specimens[J].Mol Carcinog,2000,29(3):143-150.
  • 9TANAKA M,GROSSMAN H B.In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth,downregulates phosphorylated AKT,and increases sensitivity to doxorubicin[J].Gene Ther,2003,10(19):1636-1642.
  • 10Tanaka M, Koul D, Davies M A, et al. MMAC1/PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells [J]. Oncogene,2000,19(47) :5406-5412.

共引文献29

同被引文献8

  • 1孙长成,孔垂泽,李泽良,王侠,杨春明.肾癌组织中Pten/MMAC1/Tep1的表达及临床意义[J].中华肿瘤防治杂志,2007,14(11):847-849. 被引量:3
  • 2郭永连,周四维,张小平,叶章群.抑癌基因在膀胱癌组织中的表达及其与Akt磷酸化的相关性[J].临床泌尿外科杂志,2007,22(7):544-546. 被引量:5
  • 3Warren S,Gates O. Multiple primary malignant tumors:a survery of the literature and a statictioal study[J].Am J Cancer,1932,(5):1358-1414.
  • 4Kotake T,Kiyohara H. Multiple primary cancers (MPC) associated with bladder cancer:an analysis of the clinical and autopsy cases in Japan[J].Jpn J Clin Onco 1,1985,(Suppl 1):S201-S210.
  • 5Quint LE,Park CH,Iannettoni MD. Solitary pulmonary nodules in patients with extrapulmonary neoplasms[J].{H}RADIOLOGY,2000,(1):257-261.
  • 6Cmifano J,Westra WH,Meininger G. Genetic progression and elonal relationgship of recurrent premalignant head and neck lesions[J].{H}Clinical Cancer Research,2000,(2):347-352.
  • 7Mydlo JH,G erstein M. Patients with urologic cancer and other nonurologic malignancies:analysis of a sample and review of the literature[J].{H}UROLOGY,2001,(6):864-869.
  • 8王成峰,邵永孚,张海增,兰忠民.多原发恶性肿瘤[J].中国肿瘤临床,2000,27(6):439-442. 被引量:71

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部